Charles Cox: Clinical Trials

3 trials sponsored by Charles Cox, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 no longer available, 1 unknown, 1 withdrawn. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Unknown 1, Withdrawn 1
Phase 21Withdrawn 1

Follow Charles Cox: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Stem Cell Study for Long COVID-19 Neurological Symptoms
Stem Cell - Post-Acute COVID-19 Syndrome
Phase 1UnknownCharles Cox122024-01-012023-12-05
Safety Study of Umbilical Cord Blood To Treat Pediatric Traumatic Brain Injury
Autologous cord blood - Traumatic Brain Injury
Phase 1 / Phase 2WithdrawnCharles Cox2011-01-012015-12-10
ACT for CP Individual Patient Expanded Access IND Protocol
Autologous Cord Blood Stem Cells - Cerebral Palsy
No longer availableCharles Cox2020-05-13

Conditions studied

Brain Injuries, Traumatic (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Cerebral Palsy (1)  ·  Post-Acute COVID-19 Syndrome (1)

Countries

United States (3)

Top investigators

Charles S Cox, Jr., MD (1)  ·  Charles S Cox, MD (1)  ·  Charles S. Cox, MD (1)

Results publications

PMID 27856631, PMID 32427134, PMID 32637987, PMID 32934000, PMID 33031513, PMID 33172844, PMID 33347790, PMID 33391730, PMID 33413026, PMID 33428867, PMID 33755344, PMID 33764478, PMID 33912905, PMID 34245450, PMID 34255355, PMID 34265229, PMID 34308300, PMID 34676578, PMID 34790680, PMID 34913540, PMID 35156065